Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study (Q28219713)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 18 August 2007)

Language	Label	Description	Also known as
English	Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study	scientific article (publication date: 18 August 2007)

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

17

object named as

Young-Bae Park

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

3

object named as

Kyung-Woo Park

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1

object named as

Bon-Kwon Koo

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

7

object named as

Joo-Yong Hahn

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

9

object named as

Jin-Shik Park

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

author name string

Yong-Seok Kim

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Han-Mo Yang

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Dong-A Kwon

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Jin-Wook Chung

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hyun-Jae Kang

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Young-Seok Cho

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Tae-Jin Youn

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Woo-Young Chung

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

In-Ho Chae

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Dong-Ju Choi

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Hyo-Soo Kim

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

language of work or name

0 references

publication date

1 August 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

370

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

9587

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

567-574

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcome following aleatory implantation of paclitaxel-eluting or sirolimus-eluting stents in complex coronary lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-sirolimus-eluting stent restenosis treated with repeat percutaneous intervention: late angiographic and clinical outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib induces apoptosis by inhibiting 3-phosphoinositide-dependent protein kinase-1 activity in the human colon cancer HT-29 cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical end points in coronary stent trials: a case for standardized definitions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study to assess the effectiveness of slow- and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sirolimus-eluting stent versus paclitaxel-eluting stent for patients with long coronary artery disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical outcomes and stent thrombosis following off-label use of drug-eluting stents

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Safety and efficacy of short-term celecoxib before elective percutaneous coronary intervention for stable angina pectoris.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective COX-2 inhibition improves endothelial function in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of cyclooxygenase-2 inhibition with rofecoxib on endothelial dysfunction and inflammatory markers in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Sulfone COX-2 inhibitors increase susceptibility of human LDL and plasma to oxidative modification: comparison to sulfonamide COX-2 inhibitors and NSAIDs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib for the prevention of sporadic colorectal adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib does not affect the antiplatelet activity of aspirin in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Celecoxib for the prevention of colorectal adenomatous polyps

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclooxygenase-2 inhibitors enhance shear stress-induced platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2807%2961295-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(07)61295-1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17707751%20AND%20SRC:MED&resulttype=core&format=json

3 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28219713&oldid=1857423179"